MSD Animal Health completes acquisition of Elanco’s aqua business

Rick DeLuca, president, MSD Animal Health, is excited to welcome new colleagues to MSD Animal Health.

RAHWAY, N.J. — MSD Animal Health, a division of Merck & Co., Inc., in Rahway, N.J., USA, has recently completed the acquisition of Elanco Animal Health Inc’s aqua business.

This strategic move bolsters MSD Animal Health’s presence in the aquaculture industry, exemplifying a comprehensive commitment to enhancing fish health, welfare and sustainability across aquaculture, conservation and fisheries.

“With the completion of this acquisition, we are well positioned within the aquaculture industry with a robust and comprehensive portfolio across warm water, cold water, vaccines, anti-parasitic treatments, water supplements and nutrition,” said Rick DeLuca, president, MSD Animal Health.

“We are excited to welcome our new colleagues to MSD Animal Health and we look forward to working together, driven by our common purpose of the Science of Healthier Animals,” he said.

Following this acquisition, MSD Animal Health now possesses innovative products like CLYNAV, a groundbreaking DNA-based vaccine safeguarding Atlantic salmon from pancreas disease, and IMVIXA – an anti-parasitic treatment for sea lice, alongside water treatment products for warm water production, synergistically complementing MSD Animal Health’s prevailing vaccine offerings.

The increasing utilisation of medications, vaccines, nutritional supplements and products for aquatic species is motivated by the rising global demand for protein and food safety, ensuring the provision of high-quality food and safeguarding public health.

MSD upholds a unified mission of leveraging cutting-edge science to safeguard and enhance lives worldwide. With over a century of pioneering research, the company continues to develop and offer medicines, vaccines and pioneering health solutions for some of the most challenging global diseases.

MSD Animal Health, the global animal health entity of MSD under Merck & Co., Inc., Rahway, N.J., USA, is deeply committed to The Science of Healthier Animals. Offering veterinarians, farmers, producers, pet owners and governments an extensive array of veterinary pharmaceuticals, vaccines, health management solutions and services, along with a suite of connected technologies encompassing identification, traceability and monitoring products, MSD Animal Health is dedicated to advancing the health, well-being and performance of animals and their caretakers.

The company invests extensively in cutting-edge R&D resources and maintains a modern, global supply chain. Present in over 50 countries, MSD Animal Health’s products are accessible in approximately 150 markets worldwide.